Check out the companies making headlines in extended trading: Palantir — The defense technology stock advanced 4% after second-quarter earnings exceeded Wall Street’s expectations. Palantir said it reported adjusted earnings of 16 cents per share on $1 billion in revenue, while analysts polled by LSEG anticipated 14 cents in earnings per share and $940 million in revenue. Vertex Pharmaceuticals — The biotech stock sank 14% after second-quarter earnings topped estimates. Vertex posted adjusted earnings of $4.52 per share on revenue of $2.96 billion, while analysts surveyed by LSEG had penciled in $4.26 in earnings per share and $2.91 billion in revenue. Hims & Hers Health — Shares tumbled 12% after the telehealth company issued disappointing guidance. Hims sees third-quarter adjusted earnings before interest, taxes, depreciation and amortization ranging from $60 million to $70 million, while StreetAccount consensus estimates called for $77 million. Second-quarter results were mixed, with revenue missing expectations, while adjusted earnings narrowly beat. Syndax Pharmaceuticals — The biopharma stock slipped 3% after Syndax guided for a third-quarter research and development expense of between $95 million and $100 million, while analysts polled by FactSet had expected $65.8 million. However, the company posted second-quarter revenue that exceeded expectations, as well as a narrower-than-expected loss per share. Dorman Products — The vehicle parts supplier popped 7% after hiking its full-year earnings guidance to between $8.60 and $8.90 per share, excluding items, from a range of $7.55 to $7.85 a share. Dorman also issued better-than-expected top- and bottom-line results for the second quarter, per FactSet. V2X — Shares rose more than 2% after the aerospace and defense company’s second-quarter results beat Wall Street’s expectations. V2X posted adjusted earnings of 33 cents per share, while analysts polled by FactSet had penciled in 97 cents per share. The company’s revenue of $1.08 billion also beat the consensus estimate of $1.05 billion. Additionally, it raised its full-year earnings forecast. MercadoLibre — Shares dropped 4% after the Latin American e-commerce platform reported second-quarter earnings that missed expectations. MercadoLibre posted earnings of $10.31 per share, below the $11.93 per share estimated by analysts polled by FactSet. On the other hand, expected revenue of $6.79 billion topped the $6.67 billion consensus estimate. — CNBC’s Darla Mercado, Sean Conlon, Lisa Kailai Han and Sarah Min contributed reporting.
Recent Posts
- What is a non-compete clause under Federal employment law Toronto?
- 웹사이트 검색누락 페이지 수 많아도 되나요?
- 평가는 강남달토가 좋은 편이야?
- Does unjust dismissal Canada apply to federal employees?
- Can the Instagram API monitor account growth trends?
- The Cost vs. Value Debate: Decen Masters Scam or Legit?
- Is a Mobile locksmith suitable for new lock installs?
- Does unjust dismissal apply to managerial employees?
- 해외스포츠중계 보안 괜찮나요?
- 무료 스포츠중계 사이트는 다양한 스포츠를 제공하나요?
- 레플리카 구매 위험은 무엇인가요?
- Descriptive and Diagnostic Analytics Frameworks: Understanding the Stories Hidden in Data
- Can I sue HR with a workplace harassment lawyer?
- Do they offer luxury vans in the best car rental with driver in Mumbai?
- What are common mistakes in B2B network marketing?
- From Self-Talk to Inner Peace
- Naturium Body Wash Makes An ‘Immediate Difference’ On Crepey Skin
- The Crossword: Wednesday, September 17, 2025
- Explore India’s best stargazing spots, tips for first-timers, and expert insights from space enthusiasts
- Trigun Deluxe Edition Manga Gets Limited-Time 50% Discount At Amazon
Archives
- May 2026
- April 2026
- March 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- October 2023
- February 2021





